Calcium, an essential mineral, plays a pivotal role in sustaining the health and function of the human skeletal system. Its significance in bone metabolism is a subject of great interest in medical science. This article aims to provide a comprehensive review of calcium's integral role in bone metabolism, elucidating its mechanisms and clinical implications.
Calcium is the most abundant mineral in the human body, with 99% stored in the bones and teeth. It contributes to bone strength and structure, and is involved in critical metabolic functions such as nerve transmission, muscle contraction, and blood clotting. The interplay between dietary calcium intake, absorption, excretion, and bone remodeling underscores its role in maintaining bone health.
Bone remodeling, a continuous process of bone formation and resorption, is significantly influenced by calcium levels. Osteoblasts (cells responsible for bone formation) and osteoclasts (cells responsible for bone resorption) work in tandem to maintain bone homeostasis. Any imbalance in this process, often linked to calcium deficiencies, can lead to bone diseases such as osteoporosis.
Calcium homeostasis is a tightly regulated process involving the parathyroid hormone (PTH) and vitamin D. PTH increases blood calcium levels by stimulating osteoclast activity and enhancing renal reabsorption of calcium. Vitamin D promotes intestinal absorption of calcium. Disruptions in this regulatory system can result in hypercalcemia or hypocalcemia, with potential adverse effects on cardiovascular, renal, and neurological health.
Understanding the integral role of calcium in bone metabolism is crucial for healthcare professionals. It informs the approach to prevention, diagnosis, and treatment of bone-related diseases. Further research into the complex interactions between calcium, bone health, and overall metabolism will undoubtedly enhance our ability to manage and prevent skeletal disorders effectively.
1.
Expert Q&A: A Drug Holiday for Metastatic Prostate Cancer?
2.
Ivonescimab Tops Pembrolizumab in PD-L1-Positive, Advanced NSCLC
3.
Weight loss trial reports success for breast cancer patients at one year mark
4.
Tissue-Free ctDNA Strongly Prognostic of Recurrence in TNBC
5.
Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients
1.
Navigating the Challenges of Vaso-Occlusive Crisis: A Guide for Patients and Caregivers
2.
Single-Cell Lineage Tracing in Hematology: Decoding the Cellular Blueprint of Blood Disorders
3.
AI-Powered Strategies for Precision and Improved Outcomes in Esophageal Cancer, a Global Health Crisis
4.
Unlocking the Power of Neutrophils: Harnessing Their Disease-Fighting Potential
5.
Epigenetic Subtyping of Complex Hematologic Disorders
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Updates on the First Line Management of ALK+ NSCLC
2.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
3.
Navigating the Complexities of Ph Negative ALL - Part V
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
5.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation